RLMD 0.63 (-77.26%)
US75955J4022Drug ManufacturersDrug Manufacturers - Specialty & Generic

Relmada Therapeutics (RLMD) Competitor Comparison

We are evaluating the key criteria listed to compare Relmada Therapeutics (RLMD) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - RLMD ranking 38 / 54

These are the competitors of Relmada Therapeutics in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Phibro Animal Health PAHC
79.06
2. ANI Pharmaceuticals ANIP
53.47
3. ProPhase Labs PRPH
32.25
4. Evolus EOLS
20.56
5. Green Thumb Industries R9U2.F
18.34
6. Catalent CTLT
15.64
7. Regencell Bioscience Holdings RGC
13.6
8. Organogenesis Holdings ORGO
13.02
9. Alvotech ALVO
10.26
10. Kamada KMDA
9.94
11. Neoleukin Therapeutics NLTX
8.58
12. Alimera Sciences ALIM
7.82
13. Vifor Pharma G2AB.F
7.23
14. PetIQ PETQ
6.43
15. Linc LNC
5.18
16. Zoetis ZTS
5.06
17. Kolinpharma KIP.MI
4.88
18. Perrigo PRGO
4.72
19. Curaleaf Holdings CURLF
4.43
20. Pacira BioSciences PCRX
4.2
21. Elanco Animal Health ELAN
4
22. Journey Medical DERM
3.86
23. Ayr Wellness 3KJB.F
3.71
24. Collegium Pharmaceutical COLL
3.6
25. Taro Pharmaceutical Industries TARO
3.55
26. Ironwood Pharmaceuticals IRWD
3.46
27. Supernus Pharmaceuticals SUPN
3.45
28. Cronos Group CRON
2.84
29. Emergent BioSolutions EBS
2.83
30. Avadel Pharmaceuticals AVDL
2.65
31. Procaps Group PROC
2.59
32. Embecta EMBC
2.57
33. Bausch Health Companies BHC
2.55
34. Zynerba Pharmaceuticals ZYNE
2.47
35. Jupiter Wellness JUPW
2.39
36. Theratechnologies THTX
2.38
37. Cumberland Pharmaceuticals CPIX
2.31
38. Relmada Therapeutics RLMD
2.25
39. Societal CDMO SCTL
2.21
40. Eagle Pharmaceuticals EGRX
2.19
41. Teva Pharmaceutical Industries TEVA
2.18
42. SCYNEXIS SCYX
1.99
43. Solid Biosciences SLDB
1.95
44. Alpha Teknova TKNO
1.9
45. Clever Leaves Holdings CLVR
1.87
46. OptiNose OPTN
1.83
47. Tilray Brands TLRY
1.78
48. Ascend Wellness Holdings AAWH
1.77
49. Biofrontera BFRI
1.74
50. Flora Growth FLGC
1.63
51. Universe Pharmaceuticals UPC
1.61
52. Amphastar Pharmaceuticals AMPH
1.54
53. Amneal Pharmaceuticals AMRX
1.25
54. Harrow Health HROW
0.42

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.